By Tang W, Lu X, Zhu Z, Yu D, Liu H, Song Y, Shen L, Yu Y, Zhao Y and Xie Y (2025). Front. Immunol. 16:1624095. doi: 10.3389/fimmu.2025.1624095
The Reviewer Ahmed Tawfik Moustafa’s affiliation “Institut Pasteur de Paris, France” was erroneously given as “Institut Pasteur de Lille, France”.
The original version of this article has been updated.
Keywords: chronic disease, inactivated quadrivalent influenza vaccine, 23-valent pneumococcal polysaccharide vaccine, simultaneous administration, immunogenicity, safety
Citation: Frontiers Production Office (2025) Correction: The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases. Front. Immunol. 16:1682368. doi: 10.3389/fimmu.2025.1682368
Received: 08 August 2025; Accepted: 08 August 2025;
Published: 20 August 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, bWFpbHRvOnByb2R1Y3Rpb24ub2ZmaWNlQGZyb250aWVyc2luLm9yZw==